The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 27, 2012

Filed:

Aug. 04, 2009
Applicants:

Stuart Norman Lile Bennett, Macclesfield, GB;

Roger John Butlin, Macclesfield, GB;

Leonie Campbell, Macclesfield, GB;

Robert Darren Morse Davies, Macclesfield, GB;

Graeme Richard Robb, Macclesfield, GB;

Rolf Peter Walker, Macclesfield, GB;

Michael James Waring, Macclesfield, GB;

Helen Claire Pointon, Macclesfield, GB;

Mikael Dan Brink, Mölndal, SE;

Jonas Rickard Fägerhag, Mölndal, SE;

Ulrik Jurva, Mölndal, SE;

Volker Schnecke, Mölndal, SE;

Anette Marie Svensson Henriksson, Mölndal, SE;

Christer Ralf Westerlund, Mölndal, SE;

Peter Gustaf Bonn, Mölndal, SE;

Inventors:

Stuart Norman Lile Bennett, Macclesfield, GB;

Roger John Butlin, Macclesfield, GB;

Leonie Campbell, Macclesfield, GB;

Robert Darren Morse Davies, Macclesfield, GB;

Graeme Richard Robb, Macclesfield, GB;

Rolf Peter Walker, Macclesfield, GB;

Michael James Waring, Macclesfield, GB;

Helen Claire Pointon, Macclesfield, GB;

Mikael Dan Brink, Mölndal, SE;

Jonas Rickard Fägerhag, Mölndal, SE;

Ulrik Jurva, Mölndal, SE;

Volker Schnecke, Mölndal, SE;

Anette Marie Svensson Henriksson, Mölndal, SE;

Christer Ralf Westerlund, Mölndal, SE;

Peter Gustaf Bonn, Mölndal, SE;

Assignee:

Astrazeneca AB, Sodertalje, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/90 (2006.01); A61K 31/519 (2006.01); C07D 487/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

A compound of Formula (I): is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.


Find Patent Forward Citations

Loading…